Contact sensitization in patients with suspected cosmetic intolerance: Results of the IVDK 2006-2011

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 6, 2015, Pages 1071-1081

  Dinkloh, A ^a   Worm, M ^a   Geier, J ^b   Schnuch, A ^b   Wollenberg, A ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 PHENOXYETHANOL; 4 HYDROXYBENZOIC ACID ESTER; 5 CHLORO 2 METHYL 4 ISOTHIAZOLIN 3 ONE; AMERCHOL L 101; BALSAM; BUFEXAMAC; CINNAMYL ALCOHOL; CITRAL; COBALT; COCAMIDOPROPYL BETAINE; CONTACT ALLERGEN; COSMETIC; DEODORANT AGENT; DICHROMATE POTASSIUM; DISULFIRAM; GALLIC ACID; HEXADECANOL; ISOEUGENOL; LANOLIN ALCOHOL; NICKEL; OINTMENT BASE; PERFUME; SOAP; TITANIUM DIOXIDE; 2-METHYL-4-ISOTHIAZOLIN-3-ONE; 5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE; BALSAM PERU; NONSTEROID ANTIINFLAMMATORY AGENT; PRESERVATIVE; SKIN CREAM; SUNSCREEN; THIAZOLE DERIVATIVE;

ADULT; ARTICLE; ATOPIC DERMATITIS; CONTACT SENSITIZATION; CONTROLLED STUDY; CREAM; DATA ANALYSIS; EYELID; FACE; FEMALE; GEL; HAND; HUMAN; LEG; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN ALLERGY; AGED; DERMATITIS, ALLERGIC CONTACT; MIDDLE AGED; PATCH TEST; YOUNG ADULT;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BALSAMS; BUFEXAMAC; COSMETICS; DERMATITIS, ALLERGIC CONTACT; FEMALE; HUMANS; MALE; MIDDLE AGED; PATCH TESTS; PERFUME; PRESERVATIVES, PHARMACEUTICAL; RETROSPECTIVE STUDIES; SKIN CREAM; SUNSCREENING AGENTS; THIAZOLES; YOUNG ADULT;

EID: 84929655103     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12750     Document Type: Article

References (53)

1. Duarte I, Campos Lage AC,. Frequency of dermatoses associated with cosmetics. Contact Dermatitis 2007; 56: 211-213.
2. Kohl L, Blondeel A, Song M,. Allergic contact dermatitis from cosmetics. Retrospective analysis of 819 patch-tested patients. Dermatology 2002; 204: 334-337.
3. Orton DI, Wilkinson JD,. Cosmetic allergy: incidence, diagnosis, and management. Am J Clin Dermatol 2004; 5: 327-337.
4. Schnuch A,. Report on the national pilot studies on a harmonized and pragmatic cosmetovigilance system in the partial agreement member states. Symposium "Cosmetovigilance" organized by AGES, Vienna, 27.10. 2005
5. Schnuch A, Uter W, Geier J, Gefeller O, for the IVDK study group. Epidemiology of contact allergy: an estimation of morbidity employing the clinical epidemiology and drug-utlilization research (CE-DUR) approach. Contact Dermatitis 2002; 47: 32-39.
6. Schnuch A,. Unerwünschte Reaktionen auf Kosmetika. Eine Übersicht. Derm Beruf Umwelt 2006; 54: 140-159.
7. Travassos AR, Claes L, Boey L, Drieghe J, Gossens A,. Non-fragrance allergens in specific cosmetic products. Contact Dermatitis 2011; 65: 276-285.
8. Warshaw EM, Buchholz HJ, Belsito DV, et al,. Allergic patch test reactions associated with cosmetics: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2004. J Am Acad Dermatol 2009; 60: 23-38.
9. Goossens A,. Contact-allergic reactions to cosmetics. J Allergy 2011; 2011: 467071. doi: 10.1155/2011/467071.Epub.
10. Held E, Johansen JD, Agner T, Menné T,. Contact allergy to cosmetics: testing with patients' own products. Contact Dermatitis 1999; 40: 310-315.
11. Schnuch A, Geier J, Lessmann H, Arnold R, Uter W,. Surveillance of contact allergies: methods and results of the Information Network of Departments of Dermatology (IVDK). Allergy 2012; 67: 847-857.
12. Uter W, Mackiewicz M, Schnuch A, Geier J,. Interne Qualitätssicherung von Epikutantest-Daten des multizentrischen Projektes "Informationsverbund Dermatologischer Kliniken" (IVDK). Derm Beruf Umwelt 2005; 53: 107-114.
13. Uter W, Schnuch A, Gefeller O,. Guidelines for the descriptive presentation and statistical analysis of contact allergy data. Contact Dermatitis 2005; 51: 47-56.
14. Schnuch A, Aberer W, Agathos M, et al,. Durchführung des Epikutantests mit Kontaktallergenen. Leitlinien der Deutschen Dermatologischen Gesellschaft (DDG) und der Deutschen Gesellschaft für Allergie und klinische Immunologie (DGAKI). Journal der Deutschen Dermatologischen Gesellschaft 2008; 6: 770-775.
15. Schnuch A, Geier J, Uter W, et al,. National rates and regional differences in sensitization to allergens of the standard series. Population-adjusted frequencies of sensitization (PAFS) in 40,000 patients from a multicenter study (IVDK). Contact Dermatitis 1997; 37: 200-209.
16. Schnuch A,. PAFS: population-adjusted frequency of sensitization (I). Influence of sex and age. Contact Dermatitis 1996; 34: 377-382.
17. Brasch J, Henseler T,. The reaction index-a parameter to assess the quality of patch test preparations. Contact Dermatitis 1992; 27: 203-204.
18. Geier J, Uter W, Lessmann H, Schnuch A,. The positivity ratio-another parameter to assess the diagnostic quality of a patch test preparation. Contact Dermatitis 2003; 48: 280-282.
19. Feser A, Plaza T, Vogelgsang L, Mahler V,. Periorbital dermatitis-a recalcitrant disease: causes and differential diagnoses. Brit J Dermatol 2008; 159: 858-863.
20. Boonchai W, Desomchoke R, Iamtharachai P,. Trend of contact allergy to cosmetic ingredients in Thais over a period of 10 years. Contact Dermatitis 2011; 65: 311-316.
21. Wetter DA, Yiannias JA, Prakash AV, Davis MD, Farmer SA, el-Azhary RA,. Results of patch testing to personal care product allergens in a standard series and a supplemental cosmetic series: an analysis of 945 patients from the Mayo Clinic Contact Dermatitis Group, 2000-2007. J Am Acad Dermatol 2010; 63: 789-798.
22. Schnuch A, Geier J, Uter W, Frosch PJ,. Another look at allergies to fragrances: frequencies of sensitisation to the fragrance mix and its constituents. Results from the IVDK. Exog Dermatol 2002; 1: 231-237.
23. Uter W, Geier J, Frosch PJ, Schnuch A,. Contact allergy to fragrances: current patch test results (2005 to 2008) from the Information Network of Departments of Dermatology. Contact Dermatitis 2010; 63: 254-261.
24. Krautheim A, Uter W, Frosch PJ, Schnuch A, Geier J,. Patch testing with fragrance mix II: results of the IVDK 2005-2008. Contact Dermatitis 2010; 63: 262-269.
25. Nardelli A, Drieghe J, Claes L, Boey L, Goossens A,. Fragrance allergens in 'specific' cosmetic products. Contact Dermatitis 2011; 64: 212-219.
26. Bråred Christensson J, Andersen KE, Bruze M, et al,. An international multicentre study on the allergenic activity of air-oxidized R-limonene. Contact Dermatitis 2013; 68: 214-223.
27. Goncalo M, Goossens A, on behald of the ESCD. Whilst Rome burns: the epidemic of contact allergy to methylisothiazolinone. Contact Dermatitis 2013; 68: 257-258.
28. Lundov MD, Krongaard T, Menne TL, Johansen JD,. Methylisothiazolinone contact allergy: a review. Brit J Dermatol 2011; 165: 1178-1182.
29. Castanedo-Tardana MP, Zug KA,. Methylisothiazolinone. Dermatitis 2013; 24: 2-6.
30. Uter W, Geier J, Bauer A, Schnuch A,. Risk factors associated with methylisothiazolinone contact sensitization. Contact Dermatitis 2013; 69: 231-238.
31. Isaksson M, Andersen KE, Gonçalo M, et al,. Multicentre patch testing with methylisothiazolinone by the European Environmental and Contact Dermatitis Research Group. Contact Dermatitis 2014; 70: 317-320.
32. Bruze M, Isaksson M, Gruvberger B, et al,. Patch testing with methylchloroisothiazolinone/methylisothiazolinone 200 ppm aq. detects significantly more contact allergy than 100 ppm. A multicentre study within the European Environmental and Contact Dermatitis Research Group. Contact Dermatitis 2014; 71: 31-34.
33. Geier J, Lessmann H, Schnuch A, Uter W,. Recent increase in allergic reactions to methylchloroisothiazolinone/methylisothiazolinone: is methylisothiazolinone the culprit? Contact Dermatitis 2012; 67: 334-341.
34. Lee SS, Hong DK, Jeong NJ, et al,. Multicenter study of preservative sensitivity in patients with suspected cosmetic contact dermatitis in Korea. J Dermatol 2012; 39: 677-681.
35. Johansen JD, Veien N, Laurberg G, et al,. Decreasing trends in methyldibromo glutaronitrile contact allergy-following regulatory intervention. Contact Dermatitis 2008; 59: 48-51.
36. Aakhus AE, Warshaw EM,. Allergy to methyldibromoglutaronitrile/phenoxyethanol (Euxyl K 400): regulatory issues, epidemiology, clinical characteristics, and management. Dermatitis 2011; 22: 127-140.
37. Schnuch A, Lessmann H, Geier J, Uter W,. Contact allergy to preservatives. Analysis of IVDK data 1996-2009. Br J Dermatol 2011; 164: 1316-1325.
38. Thyssen JP, Engkilde K, Lundov MD, Carlsen BC, Menné T, Johansen JD,. Temporal trends of preservative allergy in Denmark (1985-2008). Contact Dermatitis 2010; 62: 102-108.
39. Mertin-Gorgojo A, Johansen J-D,. Contact dermatitis caused by iodopropynyl butylcarbamate in Denmark. Contact Dermatitis 2013; 69: 78-85.
40. Latorre N, Borrego L, Fernandez-Redondo V, et al,. Patch testing with formaldehyde and formaldehyde-releasers: multicenter study in Spain (2005-2009). Contact Dermatitis 2011; 65: 286-292.
41. Uter W, Schnuch A, Geier J, Agathos M,. Epikutantest-Reaktionen auf Paraben-Mixe und ihre Aufschlüsselungen. Studien der DKG und des IVDK, 1990-2000. Allergologie 2002; 25: 194-202.
42. de Groot A, Veenstra M,. Formaldehyde-releasers in cosmetics in the USA and in Europe. Contact Dermatitis 2010; 62: 221-224.
43. Zug KA, Warshaw EM, Fowler JF Jr, et al,. Patch-test results of the North American Contact Dermatitis Group 2005-2006. Dermatitis. 2009; 20: 149-160. Erratum. In: Dermatitis 2009; 20: 300.
44. de Groot AC, White IR, Flyvholm MA, Lensen G, Coenraads PJ,. Formaldehyde-releasers in cosmetics: relationship to formaldehyde contact allergy. Part 1. Characterization, frequency and relevance of sensitization, and frequency of use in cosmetics. Contact Dermatitis 2010; 62: 2-17.
45. Schnuch A, Uter W, Geier J, Lessmann H, Frosch PJ,. Sensitization to 26 fragrances to be labelled according to current European regulation. Results of the IVDK and review of the literature. Contact Dermatitis 2007; 57: 1-10.
46. Wakelin SH, Smith H, White IR, Rycroft RJG, McFadden JP,. A retrospective analysis of contact allergy to lanolin. Brit J Dermatol 2001; 145: 28-31.
47. Lee B, Warshaw E,. Lanolin allergy: history, epidemiology, responsible allergens, and management. Dermatitis 2008; 19: 63-72.
48. Wolf R,. The lanolin paradox. Dermatology 1996; 192: 198-202.
49. Brasch J, Henseler T, Aberer W, et al,. Reproducibility of patch tests. A multicenter study of synchronous left- versus right-sided patch tests by the German Contact Dermatitis Research Group. J Amer Acad Dermatol 1994; 31: 584-591.
50. Geier J, Weisshaar E, Lessmann H, et al,. "Bewertung der Allergene bei BK 5101" der Arbeitsgemeinschaft für Berufs- und Umweltdermatologie in der Deutschen Dermatologischen Gesellschaft. Bewertung von Epikutantestreaktionen auf "Problemallergene" mit vermehrt fraglichen oder schwach positiven Reaktionen. Derm Beruf Umwelt 2010; 58: 34-38.
51. White IR, Lovell CR, Cronin E,. Antioxidants in cosmetics. Contact Dermatitis 1984; 11: 265-267.
52. Roberts H, Williams J, Tate B,. Allergic contact dermatitis to panthenol and cocamidopropyl PG dimonium chloride phosphate in a facial hydrating lotion. Contact Dermatitis 2006; 55: 369-370.
53. Schnuch A, Mildau G, Kratz E-M, Uter W,. Risk of sensitization to preservatives estimated on the basis of patch test data and exposure, according to a sample of 3541 leave-on products. Contact Dermatitis 2011; 65: 167-174.